Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemolytic anemia.

E Beutler1, L Luzzatto

  • 1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA.

Seminars in Hematology
|December 14, 1999
PubMed
Summary
This summary is machine-generated.

Significant advancements in understanding erythrocyte disorders, including hemolytic anemia, have been made. However, effective treatments for these red blood cell conditions remain a challenge.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

1342C mutation in Gaucher's disease.

Lancet (London, England)·1995
Same author

Triosephosphate isomerase deficiency: repetitive occurrence of point mutation in amino acid 104 in multiple apparently unrelated families.

American journal of hematology·1995
Same author

Gaucher disease.

Medicine·1995
Same author

Treatment regimens in Gaucher's disease.

Lancet (London, England)·1995
Same author

Molecular study of pyruvate kinase deficient patients with hereditary nonspherocytic hemolytic anemia.

The Journal of clinical investigation·1995
Same author

Erythrocyte fragility and chronic intermittent pigmenturia in a dog.

Journal of the American Veterinary Medical Association·1995
Same journal

Pain in SCD-Many mechanisms and mysteries.

Seminars in hematology·2026
Same journal

The many facets of cardiopulmonary complications in sickle cell disease.

Seminars in hematology·2026
Same journal

Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies.

Seminars in hematology·2026
Same journal

Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.

Seminars in hematology·2026
Same journal

Telomeres biology disorders: the past, the present and the future.

Seminars in hematology·2026
Same journal

Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.

Seminars in hematology·2026
See all related articles

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • The 20th century saw a transformation in our understanding of the erythrocyte, or red blood cell.
  • Initial knowledge was limited, but significant progress has been made in comprehending red blood cell metabolism and membrane structure.

Observation:

  • Immune hemolytic disorders, particularly Rh hemolytic disease, have seen major clinical advancements.
  • Hereditary membrane disorders like spherocytosis and ovalocytosis alter red blood cell shape.
  • Acquired mutations in PIG-A cause paroxysmal nocturnal hemoglobinuria, affecting the glycosylphosphatidylinositol anchor.

Findings:

  • Red blood cell enzyme deficiencies leading to hereditary nonspherocytic hemolytic anemia are now understood at the DNA level.
  • The genetic basis of many common red blood cell disorders has been elucidated.

Related Experiment Videos

  • While understanding has grown, specific genetic mutations causing these anemias are well-characterized.

    • Implications:

    • Despite progress, the management of acquired and hereditary hemolytic anemias remains unsatisfactory.
    • Current treatment options are limited, often leaving splenectomy as the primary intervention.
    • Future therapies for hemolytic anemias may arise from the extensive knowledge gained in the 20th century.